Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 214

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

Wijsman, Ellen M., Pankratz, Nathan D., Choi, Yoonha, Rothstein, Joseph H., Faber, Kelley M., Cheng, Rong, Lee, Joseph H., Bird, Thomas D., Bennett, David A., Diaz-Arrastia, Ramon, Goate, Alison M., Farlow, Martin, Ghetti, Bernardino, Sweet, Robert A., Foroud, Tatiana M., Mayeux, Richard, The NIA-LOAD/NCRAD Family Study Group · 2011 · PLoS Genetics

Abstract

Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly. The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. This cohort represents the largest family-based GWAS of LOAD to date, with analyses limited here to the European-American subjects. SNPs near APOE gave highly significant results (e.g., rs2075650, p = 3.2×10(-81)), but no other genome-wide significant evidence for association was obtained in the full sample. Analyses that stratified on APOE genotypes identified SNPs on chromosome 10p14 in CUGBP2 with genome-wide significant evidence for association within APOE ε4 homozygotes (e.g., rs201119, p = 1.5×10(-8)). Association in this gene was replicated in an independent sample consisting of three cohorts. There was evidence of association for recently-reported LOAD risk loci, including BIN1 (rs7561528, p = 0.009 with, and p = 0.03 without, APOE adjustment) and CLU (rs11136000, p = 0.023 with, and p = 0.008 without, APOE adjustment), with weaker support for CR1. However, our results provide strong evidence that association with PICALM (rs3851179, p = 0.69 with, and p = 0.039 without, APOE adjustment) and EXOC3L2 is affected by correlation with APOE, and thus may represent spurious association. Our results indicate that genetic structure coupled with ascertainment bias resulting from the strong APOE association affect genome-wide results and interpretation of some recently reported associations. We show that a locus such as APOE, with large effects and strong association with disease, can lead to samples that require appropriate adjustment for this locus to avoid both false positive and false negative evidence of association. We suggest that similar adjustments may also be needed for many other large multi-site studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1001308

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 69

  1. R Mayeux, 2003, Epidemiology of neurodegeneration., Annu Rev Neurosci, 26, 81, 10.1146/annurev.neuro.26.043002.094919 · DOI · Paper page
  2. L Fratiglioni, 1999, Worldwide prevalence and incidence of dementia., Drugs & Aging, 15, 365, 10.2165/00002512-199915050-00004 · DOI · Paper page
  3. M Gatz, 2006, Role of genes and environments for explaining Alzheimer disease., Arch Gen Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168 · DOI · Paper page
  4. ALM Bergem, 1997, Apolipoprotein E type epsilon 4 allele, heritability and age at onset in twins with Alzheimer's disease., Clin Genet, 52, 408, 10.1111/j.1399-0004.1997.tb04362.x · DOI
  5. JM Meyer, 1998, Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel., Am J Med Genet, 81, 92, 10.1002/(SICI)1096-8628(19980207)81:1<92::AID-AJMG16>3.0.CO;2-R · DOI
  6. HO Akesson, 1969, A Population Study of Senile and Arteriosclerotic Psychoses., Hum Hered, 19, 546, 10.1159/000152266 · DOI
  7. JCS Breitner, 1986, Familial Aggregation in Alzheimer Dementia .1. a Model for the Age-Dependent Expression of an Autosomal Dominant Gene., J Psychiatr Res, 20, 31, 10.1016/0022-3956(86)90021-X · DOI
  8. RC Mohs, 1987, Alzheimers-Disease - Morbid Risk among 1st-Degree Relatives Approximates 50-Percent by 90 Years of Age., Arch Gen Psychiatry, 44, 405, 10.1001/archpsyc.1987.01800170019003 · DOI
  9. C Van Broeckhoven, 1987, Failure of Familial Alzheimers-Disease to Segregate with the A4-Amyloid Gene in Several European Families., Nature, 329, 153, 10.1038/329153a0 · DOI · Paper page
  10. TD Bird, 1988, Familial Alzheimer's disease in american descendants of the Volga Germans: probable genetic founder effect., Ann Neurol, 23, 25, 10.1002/ana.410230106 · DOI
  11. PH St. George-Hyslop, 1989, Familial Alzheimers-Disease - Progress and Problems., Neurobiol Aging, 10, 417, 10.1016/0197-4580(89)90082-1 · DOI
  12. EW Daw, 1999, Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer's disease pedigrees., Am J Hum Genet, 64, 839, 10.1086/302276 · DOI
  13. EW Daw, 2000, The number of trait loci in late-onset Alzheimer disease., Am J Hum Genet, 66, 196, 10.1086/302710 · DOI · Paper page
  14. MA Pericak-Vance, 2000, Identification of Novel Genes in Late-Onset Alzheimer's Disease., Exp Gerontol, 35, 1343, 10.1016/S0531-5565(00)00196-0 · DOI · Paper page
  15. D Blacker, 2003, Results of a high-resolution genome screen of 437 Alzheimer's Disease families., Hum Mol Genet, 12, 23, 10.1093/hmg/ddg007 · DOI · Paper page
  16. LA Farrer, 2003, Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community., Hum Mol Genet, 12, 415, 10.1093/hmg/ddg037 · DOI
  17. WK Scott, 2003, Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22., Am J Hum Genet, 73, 1041, 10.1086/379083 · DOI
  18. EM Wijsman, 2004, Evidence for a novel late-onset Alzheimer's disease locus on chromosome 19p13.2., Am J Hum Genet, 75, 398, 10.1086/423393 · DOI · Paper page
  19. L Bertram, 2005, Family-based association between Alzheimer's disease and variants in UBQLN1., N Engl J Med, 352, 884, 10.1056/NEJMoa042765 · DOI · Paper page
  20. R Rademakers, 2005, Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample., Am J Hum Genet, 77, 643, 10.1086/491749 · DOI
  21. DW Hahs, 2006, A genome-wide linkage analysis of dementia in the Amish., Am J Med Genet B Neuropsychiatr Genet, 141B, 160, 10.1002/ajmg.b.30257 · DOI
  22. JH Lee, 2006, Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean Hispanics with familial Alzheimer disease., Arch Neurol, 63, 1591, 10.1001/archneur.63.11.1591 · DOI
  23. Y Li, 2006, DAPK1 variants are associated with Alzheimer's disease and allele-specific expression., Hum Mol Genet, 15, 2560, 10.1093/hmg/ddl178 · DOI
  24. AW Butler, 2009, Meta-analysis of linkage studies for Alzheimer's disease-A web resource., Neurobiol Aging, 30, 1037, 10.1016/j.neurobiolaging.2009.03.013 · DOI
  25. A Grupe, 2007, Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants., Hum Mol Genet, 16, 865, 10.1093/hmg/ddm031 · DOI · Paper page
  26. EM Reiman, 2007, GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers., Neuron, 54, 713, 10.1016/j.neuron.2007.05.022 · DOI · Paper page
  27. L Bertram, 2008, Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE., Am J Hum Genet, 83, 623, 10.1016/j.ajhg.2008.10.008 · DOI · Paper page
  28. SE Poduslo, 2009, Genome screen of late-onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis., Am J Med Genet B Neuropsychiatr Genet, 150B, 50, 10.1002/ajmg.b.30767 · DOI
  29. JC Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease., Nat Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
  30. S Seshadri, 2010, Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease., JAMA, 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
  31. GP Jarvik, 1996, Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample., Am J Hum Genet, 58, 191
  32. AJC Slooter, 1997, Genetic epidemiology of Alzheimer disease., Epidemiol Rev, 19, 107, 10.1093/oxfordjournals.epirev.a017933 · DOI
  33. M McCarthy, 1998, Sib-pair collection strategies for complex diseases., Genet Epidemiol, 15, 317, 10.1002/(SICI)1098-2272(1998)15:4<317::AID-GEPI1>3.0.CO;2-# · doi:10.1002/(sici)1098-2272(1998)15:4<317::aid-gepi1>3.0.co;2-#
  34. G McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease., Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  35. A Chudyk, 2006, Soluble HLA class I molecules exert differentiated influence on renal graft condition., Transplant Proc, 38, 90, 10.1016/j.transproceed.2005.11.090 · DOI
  36. MV Myakishev, 2001, High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers., Genome Res, 11, 163, 10.1101/gr.157901 · DOI · Paper page
  37. JR Hawkins, 2002, Miniaturized sealed-tube allele-specific PCR., Hum Mutat, 19, 543, 10.1002/humu.10060 · DOI
  38. LM Bekris, 2008, Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels., J Alzheimers Dis, 13, 255, 10.3233/JAD-2008-13303 · DOI · Paper page
  39. HHH Göring, 1997, Relationship estimation in affected rib pair analysis of late-onset diseases., Eur J Hum Genet, 5, 69, 10.1159/000484736 · DOI
  40. L Sun, 2002, Enhanced pedigree error detection., Hum Hered, 54, 99, 10.1159/000067666 · DOI
  41. DM Nielsen, 1998, Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus., Am J Hum Genet, 63, 1531, 10.1086/302114 · DOI · Paper page
  42. JK Wittke-Thompson, 2005, Rational inferences about departures from Hardy-Weinberg equilibrium., Am J Hum Genet, 76, 967, 10.1086/430507 · DOI · Paper page
  43. GY Zou, 2006, The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: A cautionary note., Ann Hum Genet, 70, 923, 10.1111/j.1469-1809.2006.00267.x · DOI
  44. CB Harvey, 1998, Lactase haplotype frequencies in Caucasians: association with the lactase persistence/non-persistence polymorphism., Ann Hum Genet, 62, 215, 10.1046/j.1469-1809.1998.6230215.x · DOI
  45. EJ Hollox, 2001, Lactase haplotype diversity in the Old World., Am J Hum Genet, 68, 160, 10.1086/316924 · DOI · Paper page
  46. Y Choi, 2009, Case-control Association Testing in the Presence of Unknown Relationships., Genet Epidemiol, 35, 668, 10.1002/gepi.20418 · DOI
  47. A Jacquard, 1972, Genetic Information Given by a Relative., Biometrics, 28, 1101, 10.2307/2528643 · DOI
  48. BG Milligan, 2003, Maximum-likelihood estimation of relatedness., Genetics, 163, 1153, 10.1093/genetics/163.3.1153 · DOI · Paper page
  49. C Bourgain, 2003, Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus., Am J Hum Genet, 73, 612, 10.1086/378208 · DOI
  50. JK Pritchard, 2001, Case-control studies of association in structured or admixed populations., Theor Popul Biol, 60, 227, 10.1006/tpbi.2001.1543 · DOI · Paper page
  51. JM Chapman, 2003, Detecting disease associations due to linkage disequilibrium using haplotype tags: A class of tests and the determinants of statistical power., Hum Hered, 56, 18, 10.1159/000073729 · DOI · Paper page
  52. CE Yu, 2007, Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association., Genomics, 89, 655, 10.1016/j.ygeno.2007.02.002 · DOI
  53. SN Romas, 2002, Familial Alzheimer disease among Caribbean Hispanics - A reexamination of its association with APOE., Arch Neurol, 59, 87, 10.1001/archneur.59.1.87 · DOI
  54. NA Rosenberg, 2009, Replication of Genetic Associations as Pseudoreplication due to Shared Genealogy., Genet Epidemiol, 33, 479, 10.1002/gepi.20400 · DOI
  55. SC Heath, 2008, Investigation of the fine structure of European populations with applications to disease association studies., Eur J Hum Genet, 16, 1413, 10.1038/ejhg.2008.210 · DOI · Paper page
  56. G Lucotte, 1997, Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe., Hum Biol, 69, 253
  57. RM Corbo, 1999, Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?, Ann Hum Genet, 63, 301, 10.1046/j.1469-1809.1999.6340301.x · DOI · Paper page
  58. H Rosenmann, 2003, An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease., Neurosci Lett, 340, 29, 10.1016/S0304-3940(03)00049-1 · DOI
  59. R Dresner-Pollak, 2009, Estrogen Receptor Beta Gene Variant Is Associated with Vascular Dementia in Elderly Women., Genet Test Mol Biomarkers, 13, 339, 10.1089/gtmb.2008.0129 · doi:10.1089/gtmb.2008.0129
  60. J Little, 2009, Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement., Hum Genet, 125, 131, 10.1007/s00439-008-0592-7 · DOI · Paper page
  61. M Nelis, 2009, Genetic Structure of Europeans: A View from the North-East., PLoS ONE, 4, e5472, 10.1371/journal.pone.0005472 · DOI · Paper page
  62. L Zekraoui, 1997, High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub-Saharan Africa., Hum Biol, 69, 575
  63. BF Voight, 2005, Confounding from cryptic relatedness in case-control association studies., PLoS Genet, 1, e32, 10.1371/journal.pgen.0010032 · DOI · Paper page
  64. D Blacker, 2001, Results of a high resolution genome screen in 443 Alzheimer's disease families: the NIMH Genetics Initiative., Am J Hum Genet, 69, 498
  65. JH Lee, 2008, Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Implication of Additional Loci., Arch Neurol, 65, 1518, 10.1001/archneur.65.11.1518 · DOI
  66. A Pacini, 2005, NAPOR-3 RNA binding protein is required for apoptosis in hippocampus., Brain Res Mol Brain Res, 140, 34, 10.1016/j.molbrainres.2005.07.006 · DOI
  67. A Falkevall, 2006, Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP., J Biol Chem, 281, 29096, 10.1074/jbc.M602532200 · DOI · Paper page
  68. G Jun, 2010, Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes., 10.1001/archneurol.2010.201 · DOI · Paper page
  69. J Wakefield, 2009, Bayes Factors for Genome-Wide Association Studies: Comparison with P-values., Genet Epidemiol, 33, 79, 10.1002/gepi.20359 · DOI · Paper page

Cited by

See all 214

Metadata

Authors
Wijsman, E. M., Pankratz, N. D., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R., Goate, A. M., Farlow, M., Ghetti, B., Sweet, R. A., Foroud, T. M., Mayeux, R., & The NIA-LOAD/NCRAD Family Study Group
Venue
PLoS Genetics
Published
2011-02-17
Volume
7
Issue
2
Pages
e1001308
ISSN
1553-7404
Cited by
214
References
32
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. https://app.cochat.ai/papers/10.1371/journal.pgen.1001308
The paper
Wijsman, E. M., Pankratz, N. D., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R., Goate, A. M., Farlow, M., Ghetti, B., Sweet, R. A., Foroud, T. M., Mayeux, R., & The NIA-LOAD/NCRAD Family Study Group. (2011). Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1001308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.